Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Amortization of Deferred Charges: 2011-2023

Historic Amortization of Deferred Charges for Mimedx Group (MDXG) over the last 12 years, with Dec 2023 value amounting to $505,000.

  • Mimedx Group's Amortization of Deferred Charges rose 95.65% to $135,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $464,000, marking a year-over-year increase of 2.43%. This contributed to the annual value of $505,000 for FY2023, which is 8.14% up from last year.
  • Latest data reveals that Mimedx Group reported Amortization of Deferred Charges of $505,000 as of FY2023, which was up 8.14% from $467,000 recorded in FY2022.
  • Mimedx Group's Amortization of Deferred Charges' 5-year high stood at $2.3 million during FY2020, with a 5-year trough of $467,000 in FY2022.
  • In the last 3 years, Mimedx Group's Amortization of Deferred Charges had a median value of $505,000 in 2023 and averaged $675,667.
  • As far as peak fluctuations go, Mimedx Group's Amortization of Deferred Charges soared by 944.53% in 2019, and later plummeted by 55.73% in 2022.
  • Mimedx Group's Amortization of Deferred Charges (Yearly) stood at $1.4 million in 2019, then surged by 59.05% to $2.3 million in 2020, then tumbled by 53.65% to $1.1 million in 2021, then plummeted by 55.73% to $467,000 in 2022, then increased by 8.14% to $505,000 in 2023.